Contact
Please use this form to send email to PR contact of this press release:
Cerecor Announces FDA Acceptance of Investigational New Drug Application for CERC-007 for the Treatment of Still’s Disease
TO:
Please use this form to send email to PR contact of this press release:
Cerecor Announces FDA Acceptance of Investigational New Drug Application for CERC-007 for the Treatment of Still’s Disease
TO: